Jan 11, 2023 / 01:15AM GMT
Eric William Joseph - JPMorgan Chase & Co, Research Division - VP & Senior Analyst
All right. Good afternoon. I'm Eric Joseph, senior biotech analyst with JPMorgan. Our next presenting company is IGM Biosciences; and presenting on behalf of the company is CEO, Fred Schwarzer. There's a Q&A after the presentation. Just raise your hand. We'll bring a mic around. For those tuning in online, feel free to submit a question via the digital conference book, and we'll work those in where appropriate. So with that, Fred. Thank you.
Fred M. Schwarzer - IGM Biosciences, Inc. - CEO, President & Director
Thanks very much, Eric. Really appreciate the opportunity to talk about IGM Biosciences, perhaps my favorite subject other than my 2 sons, but really appreciate the opportunity today.
So here's our forward-looking statement disclaimer. We are going to talk about some -- make some forward-looking statements, and so I have to refer you to all the risk factors and other disclaimers in our SEC filings.
So IGM Biosciences, as you can guess from
IGM Biosciences Inc at JPMorgan Healthcare Conference Transcript
Jan 11, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers